Skip to main content

Co-infection with Campylobacter and rotavirus in less than 5 year old children with acute gastroenteritis in Nepal during 2017–2018



Diarrhoea, although easily curable, is a global cause of death for a half million children every year. Rotavirus and Campylobacter are the most common etiological agents of diarrhoea in children less than 5 years of age. However, in Nepal, these causative agents are not routinely examined for the diagnosis and treatment. The main objective of this study was to determine Campylobacter co-infection associated with rotavirus diarrhoea in children less than 5 years of age.


A cross-sectional study was conducted at Kanti Children’s Hospital (KCH), Kathmandu, Nepal from November 2017 to April 2018. A total of 303 stool specimens from children affected with diarrhoea were processed to detect rotavirus using a rapid rotavirus antigen detection test kit, and Campylobacter by microscopy, culture and biochemical tests. Antibiotic susceptibility tests of Campylobacter isolates were performed according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines 2015.


Of 303 samples, 91 (30.0%) were positive for co-infection with rotavirus and Campylobacter. Rotavirus mono-infection was detected in 61 (20.1%), and Campylobacter mono-infection was detected in 81 (26.7%) samples. Patient’s age, month of infection, untreated water and frequent soil contact were the major risk factors for infections. Clinical features such as > 9 loose motions per day, fever, vomiting, mild to moderate dehydration, diarrhea persisting 6–9 days and presence of mucus in stool were significant (p < 0.05) clinical features, and were more severe in coinfection compared to mono-infections in multivariate analysis.


The study shows a high rate of rotavirus and Campylobacter coinfection in children with diarrhoea. Diagnosis based management of diarrhoeal cases can guide the specific treatment.

Peer Review reports


Diarrhoea remains a serious health burden in children less than 5 years of age in developing countries. Globally, diarrhoea kills around 525,000 children less than 5 years of age each year [1]. The commonest etiological agents of acute watery diarrhoea in young children in developing countries are rotavirus, enterotoxigenic Escherichia coli, Shigella spp., Campylobacter jejuni and Cryptosporidium parvum [2].

Viruses are primary agents of diarrhoea during the winter in developed countries whereas bacteria are the main agents of diarrhoea in rainy season in developing countries [3]. However, rotavirus is found to be a single dominant enteric pathogen among children in most of the developed and developing countries [4]. The number of deaths attributable to rotavirus infection and associated disease in children younger than 5 years in 2008 was estimated to be 453,000 (95% CI 420,000-494,000) [5]. With the introduction of rotavirus vaccine, the number of deaths in children less than 5 years of age declined from 528, 000 in 2000 to 215, 000 in 2013; and decreased the percentage of hospitalization due to acute gastroenteritis caused by rotavirus [6, 7].

World Health Organization recommended integrating rotavirus vaccine into national immunization program [8, 9]. Although the incidence of rotavirus infection among children in developed and developing countries is similar, outcomes often vary widely with 82% of fatalities estimated to occur in developing countries [6, 10]. Rotavirus infections are an important cause of hospitalization, causing significant economic impact on poor countries [11]. Studies published on rotavirus infection in Nepal from 1999 to 2007 showed rotavirus positivity rates ranged from 17 to 39% among all hospitalized children less than 5 years [12,13,14,15]. Various published studies from 2008 to 2017 reported different prevalence rates of rotavirus infections in diarrhoeal children, ranging from 22 to 53% [16,17,18,19].

Studies revealed that co-infection does exist between enteric bacteria and viruses [20, 21]. This evidence collectively demonstrates that co-infection by bacterial and viral pathogens play a critical role in disease progression. Infectious diseases cause most of the child deaths in developing countries [22], but the etiological agents are usually unknown and can lead to overuse/misuse of antibiotics, which may exacerbate the antibiotic resistance, already a global threat [23]. This study focuses on co-infection of Campylobacter in rotavirus infected children and explores associated risk factors and clinical features.


A hospital based cross-sectional study was conducted from November 2017 to April 2018. A total of 303 stool samples were collected from Kanti Children’s Hospital (KCH), Kathmandu, Nepal. Written informed consents and clinical and demographic information were obtained from guardians/caretakers of the patient. Samples were collected from children less than 5 years of age, presenting with diarrhoea as reported by parents in hospital. The samples were tested for rotavirus using Onsite rotavirus Ag Rapid Test kit (CTK Biotech, Inc. San Diego, USA) for rapid diagnosis of rotavirus, and the samples were taken in the laboratory for the detection of Campylobacter causing infection by culture on Campylobacter blood-free selective agar base supplemented with Campy blood free selective medium (Charcoal cefoperazone deoxycholate agar, CCDA) Selective Supplement (SR0155, containing cefoperazone and amphotericin B antibiotics) (Thermo-Fischer, Oxoid, UK). The inoculated medium was incubated at 37 °C and 42 °C in microaerophilic condition for 24 to 48 h using Campy gas pack (Oxoid, UK). After incubation, colonies appeared colorless or grey and spread like droplets. A presumptive diagnosis was made by wet mount preparation for darting motility. The isolated bacteria were identified based on the morphological character of the colonies, Gram staining of the isolate (Staining was performed with the application of carbol fuchsin as gram counter stain for 5 min), oxidase test, catalase test and sensitivity to nalidixic acid (30 μg) to differentiate Campylobacter spp. from other Enterobacteriaceae. Hippurate hydrolysis test was performed for differentiation of Campylobacter spp. A total of 4 days was required for confirmed diagnosis of infection with Campylobacter. Modified Kirby-Bauer Disc diffusion technique was used for testing the susceptibility pattern of different isolates towards various classes of antibiotics in Mueller Hinton Agar (MHA) with 5% defibrinated sheep blood. Antibiotics were used according to EUCAST guidelines (2015). Data analysis was done using IBM Statistical Package for Social Sciences version 20.0 (SPSS, Inc., Chicago, IL, USA). The association among co-infection and mono-infection with rotavirus and Campylobacter was tested using the Chi-square test for differences in proportions; and logistic regression analysis was used to assess the association between infection and the risk factors. A p-value less than0.05 was considered statistically significant.


The study included three hundred and three diarrhoeal children less than 5 years of age during the study period. The highest number of patients (n = 118) were from age group 7–12 months. There were 207 (68.3%) male and 96 (31.7%) female patients.

Detection rate of pathogens

The study was focused on detection of rotavirus and Campylobacter spp., and at least one of these pathogens were detected in 233 (76.9%) samples. Among 303 children with acute watery diarrhea, rotavirus mono-infection was detected in 61 (20.1%), Campylobacter mono-infection was detected in 81 (26.7%), co-infection was detected in 91 (30.0%) (Fig. 1).

Fig. 1

Prevalence of Campylobacter and rotavirus mono- and co-infections and other infections, Nepal, 2017/18. *Other means Other than rotavirus and Campylobacter infection

Age wise distribution of different infections in children

The highest number of rotavirus mono-infection was detected in 7–12 months age group category which accounted 29 (47.5%) of total rotavirus mono-infection. Similarly, highest number of Campylobacter mono-infection 34 (42.0%) was found in the < 6 months age group. The co-infection was observed highest (35, 38.5%) in 7–12 months of age (Table 1). Distribution of different infections in children less than 5 years was not statistically significant (χ2test, p > 0.05).

Table 1 Age-related distribution of Campylobacter and rotavirus mono- and co-infections

Risk factors for different infections in children

In multivariate analysis, infection in February was associated with a decreased risk of rotavirus mono-infection [adjusted odds ratio (AOR) = 0.26, 95% CI = 0.07–0.98, p = 0.047] than in November. Except for the age group of 25–36 months, all age groups were significantly associated with decreased risk of Campylobacter mono-infection compared to < 6 months age. No soil contact (AOR = 0.06, 95%CI = 0.01–0.47, p = 0.008) was significantly associated with a decreased risk of Campylobacter mono-infection compared to frequent soil contact. Infection in January (AOR = 11.34, 95%CI = 1.27–101.27, p = 0.030) and February (AOR = 25.32, 95%CI = 2.68–238.69, p = 0.005) were significantly associated with a higher risk of co-infections compared to November (Table 2).

Table 2 Risk factors for Rotavirus and Campylobacter mono-infection and co-infection in multivariate analysis

Clinical features in different infections with diarrhea

Among children with diarrhoea, clinical presentations were as follows: 23.8, 49.2 and 27.1% cases had 3–6, 7–9 and > 9 loose motions/day respectively. 64.7% cases had fever, and 85.8% had vomiting. 75.2% had no dehydration, 23.8% had mild to moderate dehydration and 1% had severe dehydration. 31.4% cases had abdominal pain. 35.6% had diarrhoea for less than 3 days, 45.9% had diarrhoea for 3–5 days, 17.5% had diarrhoea for 6–9 days, and only 1% had diarrhoea for more than 9 days. 70.6% of patients were from Out Patient Department (OPD) and only 29.4% were from In Patient Department (IPD). 60.7% had mucus in the stool and 30.0% had pus cells in the stool.

Abdominal pain and presence of pus cells in stool were less common features, which were significantly associated with rotavirus mono-infection in multivariate analysis. Pus cells in stool was common clinical feature, while fever and vomiting were less prevalent but significantly associated with Campylobacter mono-infection in multivariate analysis. More than nine loose motions per day, fever, vomiting, and presence of mucus in stool were most striking clinical features. Mild to moderate dehydration were less common compared with no dehydration but were significantly associated with co-infections in multivariate analysis (Table 3).

Table 3 Clinical features in different infections in multivariate analysis

Antibiotic resistance patterns in Campylobacter spp.

A total of 172 Campylobacter isolates were tested for antibiotic susceptibility. Among them, resistance to different antibiotics were: ampicillin (93.6%), cephalexin (88.4%), erythromycin (73.8%), nalidixic acid (72.1%) and cotrimoxazole (59.9%). Resistance to ampicillin/sulbactam, norfloxacin, azithromycin and tetracycline were 35.1, 40.1, 46.5 and 47.1% respectively. Campylobacter isolates were resistant to gentamicin (11.6%), chloramphenicol (15.7%) and ciprofloxacin (35.1%) (Fig. 2).

Fig. 2

Antibiotic resistance patterns in isolated Campylobacter spp. (n = 172)


This hospital based cross sectional study explored the association between Campylobacter and rotavirus infections, possible risk factors and specific clinical features. In this study, most cases of acute gastroenteritis were infants. Past studies have echoed with our study that shows that diarrhea incidence peaks at age 6–11 months [24,25,26].

Our study identified that a higher frequency of diarrhoea was seen in males consistent with other studies [13, 16, 27, 28]. Males’ preponderance to develop diarrhoea can be explained by their increased susceptibility to outdoor physical activities thus exposure to unhygienic surroundings and flood-water during rainy seasons. In addition, it could be due to simply increased presentation of male patients at the hospital more than females [29].

Campylobacter and rotavirus co-infections were responsible for the one third of acute gastroenteritis cases among children less than 5 years of age visiting at the OPD and IPD clinic/vaccination unit at the KCH in Kathmandu, Nepal during November 2017–April 2018. This study confirmed previous studies where Campylobacter co-infection with rotavirus in children were high in less than 5 years of age [30, 31].

Campylobacter spp. isolation in diarrhoeal cases was high. Campylobacter is not included in the routine diagnosis protocol thus obviates the routine laboratory investigations on the important causative agents of diarrhoea in Nepal. Campylobacter was most prevalent in February. Rotavirus mono-infection was detected in one-fifth of the children, highest in the age group: 7–12 months and was consistent with other studies in Nepal and South-East Asian countries [19, 32], however, findings contrasted with few other studies from Nepal [16, 18]. It appears that infants less than 6 months of age were initially protected against severe diarrhoea, to some extent, by maternal antibodies and they seem to have acquired adequate immunity between 12 and 16 months of age [16].

Age, sex, breast feeding, water source, quality of drinking water, hygiene and education level of parents were not found to predict rotavirus mono-infection in these children. While the month of diarrhoeal illness does possess a risk for rotavirus mono-infection, a higher infection during January–February contradicts with one past study [19]. In our study, age group was the significant predictor of Campylobacter mono-infection. No soil contact was associated with a reduced risk of Campylobacteriosis compared to frequent soil contact. In Nepal, Campylobacter is not included in routine microbiological testing in patients with diarrhoea. Conventional culture of Campylobacter is time consuming and hence affects the management of diarrhoeal cases. Therefore, use of rapid sensitive molecular techniques could be useful for timely management of Campylobacteriosis [33].

In multivariate analysis, clinical picture of children with co-infection was more severe compared to mono-infection for most clinical signs taken into examination that included fever, vomiting, abdominal pain, duration of illness, hospitalization, frequency of loose motion/day and presence of mucus in stool. Our observations are consistent with a study among Korean children [34]. We observed that especially with rotavirus and Campylobacter co-infections, there was an increase in the episodes of loose motions per day, which is consistent with a study in Odisha, India [32]. A study reported from China revealed synergistic effect due to co-infection in severe childhood diarrhoea [35].

Increasing antimicrobial drug resistance by Campylobacter limits the number of therapeutic options, which makes empirical treatment more difficult. High proportions of antibiotic resistant Campylobacter isolates in our study reveals either there is antibiotic pressure or transmission of resistant bacteria from foods of animal origin [36].


In conclusion, this hospital-based cross-sectional study highlights the burden of rotavirus, Campylobacter and co-infections in childhood diarrhoea in Nepal. Rotavirus and Campylobacter associated co-infections were found to be high in this study. Campylobacter spp., which are generally not screened for in diarrheic patients in Nepal, should also be suspected and considered into the routine diagnosis protocol. Diagnosis of the right causative agents among possible multiple infectious etiologies can help to better manage the acute childhood diarrhoea.

Availability of data and materials

All data pertaining to this study are within the manuscript.





Adjusted odds ratio


Campy blood free selective medium, Charcoal cefoperazone deoxycholate agar


Confidence interval


European committee on antimicrobial susceptibility testing


In patient department


Kanti children’s hospital


Mueller hinton agar


Out patient department


Odds Ratio


  1. 1.

    World Health Organization. Diarrhoea, fact sheet. 2017. Available from: Accessed on: 20 June, 2019.

  2. 2.

    Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A, et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health. 2015;3:e564–75.

    Article  Google Scholar 

  3. 3.

    Mackenjee MKR, Coovadia YM, Coovadia HM, Hewitt J, Robins-Browne RM. Aetiology of diarrhoea in adequately nourished young African children in Durban. S Afr Ann Trop Paediatr. 1984;4:183–7.

    CAS  Article  Google Scholar 

  4. 4.

    Nyaga MM, Jere KC, Esona MD, Seheri ML, Stucker KM, Halpin RA, et al. Whole genome detection of rotavirus mixed infections in human, porcine and bovine samples co-infected with various rotavirus strains collected from sub-Saharan Africa. Infect Genet Evol. 2015;31:321–34.

    CAS  Article  Google Scholar 

  5. 5.

    Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J. Parashar UD; WHO-coordinated global rotavirus surveillance network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–41.

    Article  Google Scholar 

  6. 6.

    Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. World Health Organization-coordinated global rotavirus surveillance network. Global, regional, and National estimates of rotavirus mortality in children <5 Years of age, 2000–2013. Clin Infect Dis. 2016;62(Suppl 2):S96–S105.

    Article  Google Scholar 

  7. 7.

    Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215(11):1666–72.

    Article  Google Scholar 

  8. 8.

    Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–65.

    Article  Google Scholar 

  9. 9.

    Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006-2016. Clin Infect Dis. 2017;65(5):840–50.

    Article  Google Scholar 

  10. 10.

    Bonkoungou IJ, Damanka S, Sanou I, Tiendrébéogo F, Coulibaly SO, Bon F, et al. Genotype diversity of group a rotavirus strains in children with acute diarrhea in urban Burkina Faso, 2008–2010. J Med Virol. 2011;83:1485–90.

    Article  Google Scholar 

  11. 11.

    Bourdett-Stanziola L, Jiménez C, Ortega-Barria E. Diversity of human rotavirus G and P genotypes in Panama, Costa Rica, and the Dominican Republic. Am J Trop Med Hyg. 2008;79:921–4.

    Article  Google Scholar 

  12. 12.

    Pun SB, Nakagomi T, Sherchand JB, Pandey BD, Cuevas LE, Cunliffe NA, et al. Detection of G12 human rotaviruses in Nepal. Emer Infect Dis. 2007;13:482.

    CAS  Article  Google Scholar 

  13. 13.

    Shariff M, Deb M, Singh R. A study of diarrhoea among children in eastern Nepal with special reference to rotavirus. Indian J Med Microbiol. 2003;21:87–90.

    CAS  PubMed  Google Scholar 

  14. 14.

    Sherchand JB, Haruki K. Rotavirus diarrhoea in children and animals of urban and rural Nepal. J Nepal Health Res Counc. 2004;2:1–4.

    Google Scholar 

  15. 15.

    Uchida R, Pandey BD, Sherchand JB, Ahmed K, Yokoo M, Nakagomi T, et al. Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P [6] or P [8] and a G11P [25] strain. J Clinic Microbiol. 2006;44:3499–505.

    CAS  Article  Google Scholar 

  16. 16.

    Sherchand JB, Nakagomi O, Dove W, Nakagomi T, Yokoo M, Pandey BD, et al. Molecular epidemiology of rotavirus diarrhea among children aged < 5 years in Nepal: predominance of emergent G12 strains during 2 years. J Infect Dis. 2009;200:S182–S87.

    Article  Google Scholar 

  17. 17.

    Pandey BD and Pun SB. Trends of rotavirus in Nepal. KUMJ 2012;9:32–35.

    Article  Google Scholar 

  18. 18.

    Sherchan JB, Ohara H, Sherpa K, Sakurada S, Gurung B, Tandukar S, et al. Rotavirus nosocomial infection in children under 5 years of age: a preliminary study in Nepal. J Nepal Paedtr Soc. 2011;31:30–4.

    Article  Google Scholar 

  19. 19.

    Dhital S, Sherchand JB, Pokhrel BM, Parajuli K, Shah N, Mishra SK, et al. Molecular epidemiology of rotavirus causing diarrhea among children less than five years of age visiting national level children hospitals. Nepal BMC Pediatr. 2017;17:101.

    Article  Google Scholar 

  20. 20.

    Calvo C, Gallardo P, Torija P, Bellón S, Méndez-Echeverría A, del Rosal T, et al. Enterovirus neurological disease and bacterial coinfection in very young infants with fever. J Clinic Virol. 2016;85:37–9.

    Article  Google Scholar 

  21. 21.

    Grimprel E, Rodrigo C, Desselberger U. Rotavirus disease: impact of coinfections. Pediatr Infect Dis J. 2008;27:S3–S10.

    Article  Google Scholar 

  22. 22.

    The United Nations Children's Fund (UNICEF). Levels & Trends in Child Mortality. Report; Estimates Developed by the UN Inter-agency Group for Child Mortality Estimation. New York: United Nations Children’s Fund; 2014.

    Google Scholar 

  23. 23.

    Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middle-income countries. BMJ Glob Health. 2019;4(6):e002104.

    Article  Google Scholar 

  24. 24.

    Naficy AB, Abu-Elyazeed R, Holmes JL, Rao MR, Savarino SJ, Kim Y, et al. Epidemiology of RVA diarrhea in Egyptian children and implications for disease control. Am J Epidemiol. 1999;150(7):770–7.

    CAS  Article  Google Scholar 

  25. 25.

    Amer MA, Abdel Salam SM, Ibrahim HA, Farag MA. Detection of group a Rota virus and characterization of G type among Egyptian children with diarrhea. Egyptian J Med Microbiol. 2007;16(1):123–32.

    Google Scholar 

  26. 26.

    Fischer Walker CL, Perin J, Aryee MJ, Boschi-Pinto C, Black RE. Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review. BMC Public Health. 2012;12:220.

    Article  Google Scholar 

  27. 27.

    Klein EJ, Boster DR, Stapp JR, Wells JG, Qin X, Clausen CR, et al. Diarrhea etiology in a children's hospital emergency department: a prospective cohort study. Clin Infect Dis. 2006;43(7):807–13.

    Article  Google Scholar 

  28. 28.

    Moyo SJ, Gro N, Matee MI, Kitundu J, Myrmel H, Mylvaganam H, et al. Age specific aetiological agents of diarrhoea in hospitalized children aged less than five years in dares salaam. Tanzania BMC Pediatr. 2011;11:19.

    Article  Google Scholar 

  29. 29.

    Salim H, Karyana PG, Sanjaya-Putra GN, Budiarsa S, Soenarto Y. Risk factors of rotavirus diarrhoea in hospitalized children in Sanglah hospital, Denpasar: a prospective cohort study. BMC Gastroenterol. 2014;14:54–60.

    Article  Google Scholar 

  30. 30.

    Rajendran P, Babji S, George AT, Rajan DP, Kang G, Ajjampur SS. Detection and species identification of Campylobacter in stool samples of children and animals from Vellore, South India. Indian J Med Microbiol. 2012;30:85.

    CAS  Article  Google Scholar 

  31. 31.

    Zhu XH, Tian L, Cheng ZJ, Liu WY, Li S, Yu WT, et al. Viral and bacterial etiology of acute diarrhea among children under 5 years of age in Wuhan, China. Chin Med J. 2016;129(16):1939–44.

    Article  Google Scholar 

  32. 32.

    Shrivastava AK, Kumar S, Mohakud NK, Suar M, Sahu PS. Multiple etiologies of infectious diarrhea and concurrent infections in a pediatric outpatient-based screening study in Odisha. India Gut Pathogens. 2017;9:16.

    Article  Google Scholar 

  33. 33.

    Liu KC, Jinneman KC, Neal-McKinney J, Wu WH, Rice DH. Simultaneous identification of Campylobacter jejuni, Campylobacter coli, and Campylobacter lari with smartcycler-based multiplex quantitative polymerase chain reaction. Foodborne Pathog Dis. 2017;14(7):371–8.

    CAS  Article  Google Scholar 

  34. 34.

    Koh H, Baek SY, Shin JI, Chung KS, Jee YM. Coinfection of viral agents in Korean children with acute watery diarrhea. J Korean Med Sci. 2008;23:937–40.

    Article  Google Scholar 

  35. 35.

    Zhang J, Duan Z, Payne DC, Yen C, Pan X, Chang Z, et al. Rotavirus-specific and overall diarrhea mortality in Chinese children younger than 5 years: 2003 to 2012. Pediatr Infect Dis. 2015;34:e233.

    Article  Google Scholar 

  36. 36.

    Ghimire L, Singh DK, Basnet HB, Bhattarai RK, Dhakal S, Sharma B. Prevalence, antibiogram and risk factors of thermophilic Campylobacter spp. in dressed porcine carcass of Chitwan, Nepal. BMC Microbiol. 2014;14:85.

    Article  Google Scholar 

Download references


We would like to thank University Grants Commission, Nepal, for providing UGC Masters Research support to Mr. Vishnu Bhattarai (MRS-73/74-S&T-23) for this research work. We would like to thank Kanti Children Hospital for co-operation in sample collection. We would like to acknowledge Dr. Bipin Adhikari for his help in reviewing the manuscript. Thanks go to children and their parents who provided us sample and data. Finally, we appreciate Dr. Hannah Brindle from University of Liverpool, United Kingdom for proof reading and edits.

Ethical approval and consent to participate

The study obtained ethical approval from Ethical Review Board of Kanti Children Hospital, Maharajgunj, Kathmandu. All aspects of the study were conducted according to Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) guidelines. Written informed consent and clinical and demographic information was obtained from guardians/caretakers of the patient. Participant information was securely stored and identified by Study Number.


This research was supported by University Grants Commission (UGC-Nepal) under UGC Masters Research support to Mr. Vishnu Bhattarai (MRS-73/74-S&T-23). The funding agency has no role in the design of the study, data collection, analysis and interpretation, and manuscript writing.

Author information




VB conducted the lab work and drafting of the manuscript. KRR, MRB reviewed the subsequent version of manuscript and finalized. KRR, MRB contributed in statistical analysis and revision of the manuscript. Coordination and implementation of the study: SS, KRR, MRB contributed in conceptual design and overall method of the study. All authors read and approved the final version of manuscript.

Corresponding author

Correspondence to Megha Raj Banjara.

Ethics declarations

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bhattarai, V., Sharma, S., Rijal, K.R. et al. Co-infection with Campylobacter and rotavirus in less than 5 year old children with acute gastroenteritis in Nepal during 2017–2018. BMC Pediatr 20, 68 (2020).

Download citation


  • Campylobacter
  • Rotavirus
  • Co-infection
  • Diarrhoea
  • Children